infantile hemangiomas and congenital hemangiomas.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 6 months; 2. Diagnosis of involuting infantile hemangioma or congenital hemangioma (post-involution), with visible red patches, telangiectasia, and/or irregular skin surface requiring laser intervention; 3. The legal guardian of the subject voluntarily participates in this study and provides written informed consent; 4. The legal guardian of the subject is able to comply with the requirements of the study protocol and cooperate in completing the follow-up.
Exclusion criteria
Exclusion criteria: 1. The hemangioma is in the rapid proliferation phase; 2. The lesion site has active infection or ulceration; 3. Previous treatment of the target lesion area with laser, surgery, or systemic medication (such as propranolol) that may affect the evaluation in this study (as judged by the investigator); 4. History of photosensitive diseases or being in a photosensitive state; 5. History of keloid formation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global Aesthetic Improvement Scale(GAIS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Lesion color, texture, thickness, and composite score;Adverse Events;Overall Satisfaction Score (VAS Scale); | — |
Countries
China
Contacts
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine